Capital Flow Monitor · Sponsors · CIK 1708893
Lungpacer Medical, Inc.
260 SIERRA DRIVE, SUITE 116, EXTON, PA, 19341 · 778-655-2100
Other Health Care · Corporation· inc. BRITISH COLUMBIA, CANADA true
Fit score
—
Offering
$20.0M
Sold
$16.0M
% sold
80.0%
Investors
2
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-10-14 | D | 506(b) | $30.0M | $7.8M | 26.1% | 2 | EDGAR ↗ |
| 2026-10-08 | D/A | 506(b) | $20.0M | $12.0M | 60.0% | 2 | EDGAR ↗ |
| 2026-07-02 | D/A ·current | 506(b) | $20.0M | $16.0M | 80.0% | 2 | EDGAR ↗ |
| 2026-04-28 | D | 506(b) | $20.0M | $12.0M | 60.0% | 2 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Douglas G. Evans — Executive Officer / Director, EXTON, PA
- Joseph W. Kaufmann — Director, EXTON, PA
-
Bob Donohue — Director, EXTON, PA
1 other raise
- Peca Labs, Inc. $12.8M of $21.5M · 59.5%
- Christopher Kiple — Executive Officer, EXTON, PA
- Jan Pensaert — Director, EXTON, PA
- Jonathan Conlin — Executive Officer, EXTON, PA
- Steven E. Pfanstiel — Executive Officer, EXTON, PA
- Viral Thakkar — Executive Officer, EXTON, PA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.